Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Microvesicle-camouflaged biomimetic nanoparticles encapsulating a metal-organic framework for targeted rheumatoid arthritis therapy

Fig. 3

Cellular uptake of rhodamine B (Rhm B)-labeled formulations by (A) non-activated RAW264.7 and (B) LPS-activated RAW264.7 cells, as determined by confocal microscopy. Scale bar: 25 μm. DAPI: 4,6-diamidino-2-phenylindole; FPD: 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[folate (polyethylene glycol)-2000; LPS: lipopolysaccharide; MV: microvesicle; ZIF-8: zeolitic imidazolate framework-8

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us